Diffusion Pharmaceuticals
NASDAQ: CRVOCharlottesville, US · Founded 2015 · Delaware corporation
Founders & leadership
Diffusion Pharmaceuticals was founded in 2015 by John L. Gainer and David G. Kalergis.
JL
John L. GainerCo-founder
DG
David G. KalergisCo-founder
DR
David R. JonesExecutive
BL
Ben L. ShealyExecutive
JM
John MoynahanExecutive
SS
Stephen SimesExecutive
TB
Timothy BorisExecutive
YS
Yael SchwartzExecutive
CA
Craig AbolinExecutive
DS
David SherrisExecutive
DK
David K. KalergisNamed on SEC filing
Board
IB
Isaac BlechBoard director
Reported raises · per SEC filings
Form D private placements$134.5M disclosed across 9 rounds · 2014–2020
▶$750KraisedMay 2020 · 4 investors · PharmaceuticalsRule 506(b)
▶$750KraisedMay 2020 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert J. CobuzziDirector
- Mark T. GilesDirector
- David G. KalergisExecutive Officer, Director
- Robert W. AdamsDirector
- Thomas S. ByrneExecutive Officer
- Alan G. LevinDirector
- William K. HornungExecutive Officer
- John L. GainerDirector
- Offering amount
- $750K
- Amount sold
- $750K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$625KraisedMay 2020 · 1 investors · PharmaceuticalsRule 506(b)
▶$625KraisedMay 2020 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas S. ByrneExecutive Officer
- Alan G. LevinDirector
- Robert J. CobuzziDirector
- William K. HornungExecutive Officer
- John L. GainerDirector
- Mark T. GilesDirector
- Robert W. AdamsDirector
- David G. KalergisExecutive Officer, Director
- Offering amount
- $625K
- Amount sold
- $625K
- Sales commissions
- $100K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$783.3KraisedDec 2019 · 3 investors · PharmaceuticalsRule 506(b)
▶$783.3KraisedDec 2019 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- William K. HornungExecutive Officer
- Thomas S. ByrneExecutive Officer
- Mark T. GilesDirector
- Alan G. LevinDirector
- Robert W. AdamsDirector
- David G. KalergisExecutive Officer, Director
- John L. GainerExecutive Officer, Director
- Offering amount
- $783.3K
- Amount sold
- $783.3K
- Sales commissions
- $62.7K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$164.1KraisedJun 2019 · 3 investors · PharmaceuticalsRule 506(b)
▶$164.1KraisedJun 2019 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas S. ByrneExecutive Officer
- William K. HornungExecutive Officer
- Alan G. LevinDirector
- John L. GainerExecutive Officer, Director
- Mark T. GilesDirector
- David G. KalergisExecutive Officer, Director
- Robert W. AdamsDirector
- Offering amount
- $164.1K
- Amount sold
- $164.1K
- Sales commissions
- $13.1K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.8MraisedMar 2017 · 145 investors · PharmaceuticalsRule 506(b)
▶$15.8MraisedMar 2017 · 145 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David G. KalergisExecutive Officer, Director
- Thomas S. ByrneExecutive Officer
- John L. GainerExecutive Officer, Director
- Isaac BlechDirector
- Alan G. LevinDirector
- Robert W. AdamsDirector
- Mark T. GilesDirector
- Ben L. ShealyExecutive Officer
- Offering amount
- $25M
- Amount sold
- $15.8M
- Sales commissions
- $1.5M
- Placement agents
- Maxim Group LLC
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$85.7MraisedJan 2016 · 181 investors · PharmaceuticalsRule 506(b)
▶$85.7MraisedJan 2016 · 181 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David K. KalergisDirector
- Mark T. GilesDirector
- David R. JonesExecutive Officer
- Thomas S. ByrneDirector
- Robert W. AdamsDirector
- Ben L. ShealyExecutive Officer
- John L. GainerExecutive Officer, Director
- Alan G. LevinDirector
- Amount sold
- $85.7M
- Minimum investment
- $1
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$2.4MraisedDec 2015 · 28 investors · PharmaceuticalsRule 506(b)
▶$2.4MraisedDec 2015 · 28 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert W. AdamsDirector
- David R. JonesExecutive Officer
- Thomas E. ByrneDirector
- Ben L. ShealyExecutive Officer
- Alan LevinDirector
- Mark T. GilesDirector
- John L. GainerExecutive Officer, Director
- David G. KalergisExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $2.4M
- Minimum investment
- $5K
- First sale
- Dec 2015
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
▶$3.5MraisedSep 2014 · 30 investors · PharmaceuticalsRule 506(b)
▶$3.5MraisedSep 2014 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas E. ByrneDirector
- Ben L. ShealyExecutive Officer
- Robert W. AdamsDirector
- David G. KalergisExecutive Officer, Director
- Mark T. GilesDirector
- John L. GainerExecutive Officer, Director
- David R. JonesExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Jun 2014
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Diffusion Pharmaceuticals?
- Diffusion Pharmaceuticals was founded by John L. Gainer, David G. Kalergis in 2015.
- How much funding has Diffusion Pharmaceuticals raised?
- Diffusion Pharmaceuticals has disclosed $134.5M raised across 9 rounds.
- Where is Diffusion Pharmaceuticals headquartered?
- Diffusion Pharmaceuticals is headquartered in Charlottesville, US.